Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 29
Filter
1.
Histopathology ; 2024 May 21.
Article in English | MEDLINE | ID: mdl-38773813

ABSTRACT

Liver biopsies have consistently contributed to our understanding of the pathogenesis and aetiologies of acute liver disease. As other diagnostic modalities have been developed and refined, the role of biopsy in the management of patients with acute liver failure (ALF), acute-on-chronic liver failure (ACLF) and acute hepatitis, including acute liver injury (ALI), has changed. Liver biopsy remains particularly valuable when first-line diagnostic algorithms fail to determine aetiology. Despite not being identified as a mandatory diagnostic tool in recent clinical guidelines for the management of ALF or ACLF, many centres continue to undertake biopsies given the relative safety of transjugular biopsy in this setting. Several studies have demonstrated that liver biopsy can provide prognostic information, particularly in the context of so-called indeterminate hepatitis, and is extremely useful in excluding conditions such as metastatic tumours that would preclude transplantation. In addition, its widespread use of percutaneous biopsies in cases of less severe acute liver injury, for example in the establishment of a diagnosis of acute presentation of autoimmune hepatitis or confirmation of a probable or definite drug-induced liver injury (DILI), has meant that many centres have seen a shift in the ratio of specimens they are receiving from patients with chronic to acute liver disease. Histopathologists therefore need to be equipped to deal with these challenging specimens. This overview provides an insight into the contemporary role of biopsies (as well as explant and autopsy material) in diagnosing acute liver disease. It outlines up-to-date clinical definitions of liver injury and considers recent recommendations for the diagnosis of AIH and drug-induced, autoimmune-like hepatitis (DI-AIH).

2.
Virchows Arch ; 478(2): 191-200, 2021 Feb.
Article in English | MEDLINE | ID: mdl-32607686

ABSTRACT

Professional societies play a major role in medicine and science. The societies tend to be large with well-developed administrative structures. An additional model, however, is based on small groups of experts who meet regularly in an egalitarian model in order to discuss disease-specific scientific and medical problems. In order to illustrate the effectiveness of this model, the history and practices are examined of a long-standing successful example, the International Liver Pathology Group, better known as the Gnomes. The history shows that groups such as the Gnomes offer a number of important benefits not available in larger societies and nurturing such groups advances science and medicine in meaningful ways. The success of the Gnomes' approach provides a road map for future small scientific groups.


Subject(s)
Liver Diseases/history , Liver , Pathology, Clinical/history , Societies, Medical/history , Societies, Scientific/history , Cooperative Behavior , History, 20th Century , History, 21st Century , Humans , Liver/pathology , Liver Diseases/pathology , Models, Organizational , Pathology, Clinical/organization & administration , Societies, Medical/organization & administration , Societies, Scientific/organization & administration
4.
Hepatology ; 69(4): 1830-1832, 2019 04.
Article in English | MEDLINE | ID: mdl-30215854
5.
Am J Surg Pathol ; 41(4): 499-505, 2017 Apr.
Article in English | MEDLINE | ID: mdl-28266931

ABSTRACT

Biliary adenofibroma is a rare primary hepatic neoplasm, recognized in the World Health Organization classification, although only 14 cases have been reported to date. This series includes extended follow-up from 2 of the early case reports and 4 novel cases. Clinical history and histology were reviewed in all 6 cases. Tumor DNA was analyzed for point mutations by multiplex polymerase chain reaction and copy number alterations by array comparative genomic hybridization. The patients included 4 females and 2 males presenting between 46 and 83 years of age, with tumors ranging from 7 to 16 cm in diameter. The tumors had similar morphology, with tubules and cysts lined mainly by bland to mildly atypical cuboidal epithelium embedded in fibrous stroma. Multiplex polymerase chain reaction did not identify mutations in 4 tumors tested. Three tumors tested by array comparative genomic hybridization showed chromosomal copy number alterations, including 1 with amplifications of CCND1 and ERBB2. Three patients underwent resection with no recurrence at 21, 20, and 3 years of follow-up. One patient is alive after 14 months with no resection. Two patients with margin-positive resections had local recurrence at 1 and 6 years after surgery. No patient had distant metastasis. The distinct morphology and multiple clonal cytogenetic alterations in biliary adenofibromas indicate that the lesions are neoplastic. Amplifications of CCND1 and ERBB2 are not typical of benign neoplasms, and suggest that these tumors may have the ability to behave aggressively. However, the clinical outcomes in these patients suggest the neoplasms are only slowly progressive.


Subject(s)
Adenofibroma/diagnosis , Biomarkers, Tumor/genetics , Liver Neoplasms/diagnosis , Adenofibroma/genetics , Adenofibroma/pathology , Adenofibroma/surgery , Aged , Aged, 80 and over , Biomarkers, Tumor/analysis , Comparative Genomic Hybridization , Cyclin D1/genetics , DNA Mutational Analysis , Disease-Free Survival , Female , Gene Amplification , Gene Expression Profiling , Hepatectomy , Humans , Immunohistochemistry , Liver Neoplasms/genetics , Liver Neoplasms/pathology , Liver Neoplasms/surgery , Male , Margins of Excision , Middle Aged , Mutation , Neoplasm Recurrence, Local , Neoplasm, Residual , Polymorphism, Single Nucleotide , Receptor, ErbB-2/genetics , Time Factors , Treatment Outcome , Tumor Burden
7.
Hepatology ; 61(5): 1696-707, 2015 May.
Article in English | MEDLINE | ID: mdl-25644399

ABSTRACT

UNLABELLED: Repair of cirrhotic livers occurs, in part, by repopulation with hepatocytes through the stem/progenitor pathway. There remain many uncertainties regarding this pathway. Hepatocyte "buds" occurring in broad septa are hypothesized to be the anatomic manifestation of this pathway. Our purpose was to define a morphologic sequence of bud maturation to allow a quantitative measure of the importance of the stem/progenitor pathway in humans. Histologic sections from 37 liver resection specimens were stained with trichrome, epithelial cell adhesion molecule (EpCAM), K19, CD34, glutamine synthetase (GS), and Ki-67. Specimens were stratified by etiology (10 biliary, 22 nonbiliary, five controls) and stage. Buds were defined as clusters of hepatocytes within septa. Five levels of bud maturation (0-4) were defined by the progressive increase in hepatocyte progeny relative to cholangiocytes. Level 0 single-cell buds are K19(+) /GS(+) /EpCAM(+) /Heppar1(-) . In level 1, the progeny are morphologically hepatocytes (K19(-) /GS(+) /EpCAM(+) /Heppar1(+) ). In level 2-4 buds, hepatocytes increase and become progressively GS(-) and EpCAM(-) . Associated endothelium is CD34(+) in level 1-2 buds and becomes CD34(-) near hepatic veins in level 3-4 buds. Progeny of the bud sequence may represent up to 70% of hepatocytes (immaturity index of 70%). In biliary disease, bud number is reduced in association with duct loss and cholestatic destruction of nascent buds. CONCLUSIONS: The stem/progenitor pathway, manifested anatomically by the bud sequence, is a major mechanism for repopulation of cirrhotic livers. The bud sequence reveals some critical features of hepatic morphogenesis, including that 1) the majority of distal cholangiocytes have stem-like properties, and 2) availability of bile ducts and/or venous drainage are limiting factors for regeneration.


Subject(s)
Hepatocytes , Liver Cirrhosis , Liver/cytology , Stem Cells , Cell Proliferation , Humans , Liver Cirrhosis/pathology
8.
J Biomed Opt ; 19(11): 116006, 2014.
Article in English | MEDLINE | ID: mdl-25388810

ABSTRACT

Microcirculation lesion is a common symptom of chronic liver diseases in the form of vasculature deformation and circulation alteration. In acute to chronic liver diseases such as biliary atresia, microcirculation lesion can have an early onset. Detection of microcirculation lesion is meaningful for studying the progression of liver disease. We have combined wide-field fluorescence microscopy and a laser speckle contrast technique to characterize hepatic microcirculation in vivo without labeling in a bile-duct ligation rat fibrosis model of biliary atresia. Through quantitative image analysis of four microcirculation parameters, we observed significant microcirculation lesion in the early to middle stages of fibrosis. This bimodal imaging method is useful to assess hepatic microcirculation lesion for the study of liver diseases.


Subject(s)
Image Processing, Computer-Assisted/methods , Liver/blood supply , Microcirculation/physiology , Microscopy/methods , Animals , Biliary Atresia , Liver Cirrhosis/pathology , Liver Cirrhosis/physiopathology , ROC Curve , Rats
9.
Pathol Res Pract ; 210(7): 459-62, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24755510

ABSTRACT

Malakoplakia is an unusual chronic inflammatory condition characterized by the presence of Michaelis-Gutmann bodies. Patients with malakoplakia often have an immunodeficiency state. It is believed that malakoplakia results from a defective macrophage response to phagocytosed bacteria. Malakoplakia most commonly affects the genitourinary tract. Cases confined to the liver are rare, with only five cases described in the literature. We report two cases of malakoplakia of liver; both were incidental autopsy findings. The first case involves a 53-year-old man with systemic lupus erythematosus and chronic refractory pancytopenia who presented with febrile neutropenia. His blood culture was positive for Stenotrophomonas maltophilia and Enterococcus faecium, and he subsequently developed invasive pulmonary aspergillosis. The second case involves a 60-year-old man who presented with a mass in periorbital tissue which, on biopsy, showed inflammation and Treponema-like spirochetes. He died unexpectedly at home. Autopsy revealed adrenal gland chronic inflammation and abscess. Both cases had grossly normal livers with microscopic findings of calcified targetoid structures consistent with Michaelis-Gutmann bodies. In these cases, malakoplakia was an incidental finding confined to liver. Although asymptomatic in these cases, diagnosis in the liver may be useful to initiate a search for hepatic or non-hepatic infections.


Subject(s)
Liver Diseases/pathology , Malacoplakia/pathology , Gram-Negative Bacterial Infections/complications , Humans , Immunocompromised Host , Incidental Findings , Liver Diseases/microbiology , Lupus Erythematosus, Systemic/complications , Malacoplakia/microbiology , Male , Middle Aged , Stenotrophomonas maltophilia , Syphilis/complications
11.
Histopathology ; 64(7): 907-20, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24393125

ABSTRACT

The hepatic sinusoids comprise a complex of vascular conduits to transport blood from the porta hepatis to the inferior vena cava through the liver. Under normal conditions, portal venous and hepatic artery pressures are equalized within the sinusoids, oxygen and nutrients from the systemic circulation are delivered to the parenchymal cells and differentially distributed throughout the liver acini, and proteins of liver derivation are carried into the cardiac/systemic circulation. Liver sinusoid structures are lined by endothelial cells unique to their location, and Kupffer cells. Multifunctional hepatic stellate cells and various immune active cells are localized within the space of Disse between the sinusoid and the adjacent hepatocytes. Flow within the sinusoids can be compromised by physical or pressure blockage in their lumina as well as obstructive processes within the space of Disse. The intimate relationship of the liver sinusoids to neighbouring hepatocytes is a significant factor affecting the health of hepatocytes, or transmission of the effects of injury within the sinusoidal space. Pathologists should recognize several patterns of injury involving the sinusoids and surrounding hepatocytes. In this review, injury, alterations and accumulations within the liver sinusoids are illustrated and discussed.


Subject(s)
Hepatic Veins/pathology , Liver/blood supply , Liver/pathology , Endothelial Cells , Hepatocytes , Humans , Liver Diseases/pathology , Portal Vein/pathology , Portal Vein/physiology
12.
Best Pract Res Clin Gastroenterol ; 27(4): 471-83, 2013 Aug.
Article in English | MEDLINE | ID: mdl-24090936

ABSTRACT

The liver may be injured during the course of many systemic diseases. The mechanisms of injury can be broadly divided into four pathways: vascular, toxic, immune, and hormonal. Vascular obstruction may be an early event but is also the late common pathway from all mechanisms. Despite the large number of possible initiating factors, the end results are few, including death of hepatocytes or cholangiocytes, leading to the stereotyped syndromes of acute liver failure, non-cirrhotic portal hypertension, or cirrhosis. This small number of outcomes is a reflection of the few anatomic patterns that can be generated by microvascular obstruction. Vascular obstruction may occur by thrombosis, inflammation, or congestive injury. The innate immunity pathway is activated by endotoxin and other agents, leading to inflammatory infiltration, release of cytokines and reactive oxygen species, and necrosis. The adaptive immune pathway involves the generation of antibodies and antigen-specific cell-mediated attack on hepatic cells. Hormonal effects are principally involved when overnutrition leads to hyperinsulinemia followed by hepatocellular necrosis.


Subject(s)
Hypertension, Portal/immunology , Liver Failure, Acute/immunology , Venous Thrombosis/immunology , Animals , Cell Communication/immunology , Cytokines/immunology , Hepatocytes/immunology , Humans , Immunity, Innate/immunology , Liver Circulation/immunology , Liver Cirrhosis/immunology , Liver Failure, Acute/pathology
13.
Liver Int ; 33(4): 525-34, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23362937

ABSTRACT

BACKGROUND & AIMS: In normal human liver, glutamine synthetase (GS) is expressed in a rim of hepatocytes surrounding hepatic veins. GS expression is decreased in cirrhosis and increased in chronic hepatitis, focal nodular hyperplasia, peritumoural hyperplasia and some hepatocellular neoplasms. For the non-neoplastic conditions, there is limited information available on histological pattern of altered GS expression and the mechanisms of these changes. METHODS: We examined GS expression in 58 large specimens and 45 needle biopsies with a variety of non-neoplastic human liver conditions and in 12 normal control livers. Expression was correlated with clinical and histological disease states. RESULTS: We identified four patterns of GS expression: (i) Loss of normal perivenular expression was seen in states of chronic congestion, severe cirrhosis and zone 3 necrosis. (ii) Diffuse expression was seen in states with active hepatocellular injury and correlated with Ki-67 expression. (iii) Interface expression was seen in feathery degeneration of chronic cholestasis. (iv) GS expression in activated hepatocyte progenitor cells (HPCs) associated with small ducts and ductules was seen in fulminant hepatic failure and in early and late chronic liver disease and rarely in normal livers. CONCLUSIONS: Glutamine synthetase expression is increased in regenerating hepatocytes and in early HPCs prior to morphological evidence of hepatocellular differentiation. This may be the earliest marker of HPCs yet demonstrated. Loss of expression may be a reflection of disrupted endothelium-hepatocyte contact in hepatic vein walls caused by congestive injury as found in congestive heart failure and advanced cirrhosis.


Subject(s)
Glutamate-Ammonia Ligase/analysis , Hepatocytes/enzymology , Liver Cirrhosis/enzymology , Liver Diseases/enzymology , Liver/enzymology , Stem Cells/enzymology , Biomarkers/analysis , Biopsy, Needle , Case-Control Studies , Cell Proliferation , Hepatocytes/pathology , Humans , Immunohistochemistry , Ki-67 Antigen/analysis , Liver/blood supply , Liver/pathology , Liver Cirrhosis/classification , Liver Cirrhosis/pathology , Liver Diseases/classification , Liver Diseases/pathology , Liver Regeneration , Necrosis , Stem Cells/pathology
14.
Histopathology ; 62(3): 458-64, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23240735

ABSTRACT

AIMS: Several cases of focal nodular hyperplasia (FNH) or similar hyperplastic lesions have been reported adjacent to hepatic neoplasms, including hepatocellular carcinoma, epithelioid haemangioendothelioma and hepatoblastoma. We refer to this hyperplastic response as peritumoral hyperplasia (PTH). Here, we report eight cases of PTH adjacent to primary hepatocellular carcinomas (two) and metastatic neuroendocrine tumours (three), gastrointestinal stromal tumour (one) and colon carcinomas (two). METHODS AND RESULTS: Sections were stained with H&E and trichrome, and for glutamine synthetase, CD34 and cytokeratin 7. PTH was composed of a peritumoral rim of hyperplastic hepatocytes up to 7.0 mm wide, delimited by adjacent hepatocellular atrophy. PTH had altered plate architecture, strong glutamine synthetase expression and variable sinusoidal endothelial cell CD34 expression. The central tumour deposit typically invaded portal veins and was markedly hypervascular with CD34-positive capillaries. CONCLUSIONS: We suggest that PTH is a hyperplastic response to increased blood flow in the peritumoral parenchyma. The increased flow occurs when portal vein invasion by a hypervascular tumour causes arterio-portal shunting. While PTH shares some morphological features with FNH, it lacks the defining nodular architecture, central scar and bile ductules. PTH may be related pathophysiologically to FNH, but should be classified as a separate entity because of its distinct morphology and peritumoral location.


Subject(s)
Liver Neoplasms/pathology , Liver/pathology , Aged , Antigens, CD34/analysis , Antigens, CD34/biosynthesis , Female , Glutamate-Ammonia Ligase/analysis , Glutamate-Ammonia Ligase/biosynthesis , Humans , Hyperplasia , Immunohistochemistry , Liver/blood supply , Liver Neoplasms/blood supply , Liver Neoplasms/complications , Male , Middle Aged , Portal Vein/pathology , Young Adult
15.
J Hepatol ; 57(3): 556-63, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22617153

ABSTRACT

BACKGROUNDS & AIMS: The clinical severity of cirrhosis varies widely. We investigated whether histological sub-classification of cirrhosis using the Laennec system can discriminate different outcomes among patients with cirrhosis. METHODS: One hundred and seventy-five patients with chronic liver disease who underwent liver biopsy and showed stage 3 or 4 fibrosis between January 2001 and December 2008 were prospectively enrolled. Cirrhosis was sub-classified into three groups (4A, 4B, and 4C) according to the Laennec system. The end point was liver-related event (LRE) occurrence, including decompensation, hepatocellular carcinoma, and liver-related death. RESULTS: The median age of the patients (110 men, 65 women) was 55 years. Stages 3, 4A, 4B, and 4C were identified in 46 (26.3%), 16 (9.1%), 82 (46.9%), and 31 (17.7%) patients, respectively. During the follow-up period, LREs occurred in 32 (18.3%) patients: 4 (8.7%) with stage 3, 2 (12.5%) with stage 4A, 17 (20.7%) with stage 4B, and 9 (29.0%) with stage 4C. In a multivariate analysis, histological sub-classification of cirrhosis independently predicted LRE occurrence. While patients with stage 4A tended to be at higher risk of LRE occurrence than those with stage 3, patients with stages 4B and 4C had significantly higher risks of LRE occurrence, with hazard ratios of 6.158 (p=0.016) and 8.945 (p=0.004), respectively. CONCLUSIONS: Histological sub-classification of cirrhosis using the Laennec system can be used to assess the risk of LRE occurrence among patients with cirrhosis. Our study provides a solid basis for further studies of non-invasive methods for monitoring the risk of LRE occurrence and will help physicians to establish optimum treatment strategies.


Subject(s)
Carcinoma, Hepatocellular/etiology , Liver Cirrhosis/classification , Liver Cirrhosis/pathology , Liver Failure/etiology , Liver Neoplasms/etiology , Severity of Illness Index , Adolescent , Adult , Aged , Alanine Transaminase/blood , Aspartate Aminotransferases/blood , Bilirubin/blood , Biopsy , Elasticity Imaging Techniques , Female , Humans , Kaplan-Meier Estimate , Liver Cirrhosis/complications , Liver Failure/mortality , Male , Middle Aged , Multivariate Analysis , Platelet Count , Prognosis , Proportional Hazards Models , Prospective Studies , Prothrombin Time , Risk Assessment , Serum Albumin , Young Adult , alpha-Fetoproteins
17.
Hepatol Res ; 37 Suppl 2: S139-41, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17877475

ABSTRACT

1. The precursor lesions for the development of hepatocellular carcinoma are believed to be high-grade dysplastic nodules. These lesions have atypical and proliferative features that distinguish them from normal or cirrhotic liver but are not sufficient for the diagnosis of carcinoma. 2. Individual HGDN are often heterogeneous and complete sampling may reveal regions of carcinoma within these otherwise benign lesions. 3. Invasion of stroma is considered a definitive feature of HCC. However, this feature is not always present in early HCC and is seldom found in needle biopsies. 4. Accurate diagnosis of dysplastic nodules and well-differentiated HCC requires skill and experience. However, accurate diagnosis with needle biopsies may be impossible if the highest grade of atypia is not sampled. Fine needle aspiration is not appropriate for small lesions that are expected to be early hepatic neoplasia. This technique should be reserved for suspected moderate- or poorly differentiated HCC.

18.
Hepatology ; 42(1): 53-62, 2005 Jul.
Article in English | MEDLINE | ID: mdl-15954109

ABSTRACT

Although the natural history of autoimmune hepatitis (AIH) has been characterized, little is known about patients who present asymptomatically. Consequently, whether they require immunosuppressive therapy with its associated complications is unclear. To compare the natural history of asymptomatic AIH with symptomatic AIH, a large cohort of patients from a single center was examined. All patients with a clinical diagnosis of AIH were reassessed using the revised criteria of the International Autoimmune Hepatitis Group. Liver histology, response to therapy, and survival were assessed. Patients asymptomatic at presentation (n = 31) had lower serum aminotransferase, bilirubin, and immunoglobulin G (IgG) values at baseline. Half of the asymptomatic patients received no therapy, and their survival was no different from that of the total cohort. Ten-year survival was 80.0% (62.5%-97.5%) in the asymptomatic group and 83.8% (75.1%-92.6%) in the symptomatic patients (P = NS). Survival to liver-related endpoints at 10 years was similar in both groups: 89.5% (75.7%-100%) asymptomatic and 83.8% (75.1%-92.6%) symptomatic patients (P = NS). Patients with cirrhosis at baseline had poorer 10-year survival (61.9% [CI 44.9%-78.9%]) than those without cirrhosis at presentation (94.0% [CI 87.4%-100%]) (P = .003) regardless of whether they presented with symptoms or whether they received immunosuppressive therapy. In conclusion, patients with AIH who are asymptomatic at presentation have a good prognosis and may not require immunosuppressive therapy. Cirrhosis on initial liver biopsy portends a poor prognosis in all patients with AIH.


Subject(s)
Hepatitis, Autoimmune/physiopathology , Liver Cirrhosis/pathology , Adolescent , Adult , Aged , Child , Cohort Studies , Disease Progression , Female , Hepatitis, Autoimmune/complications , Hepatitis, Autoimmune/diagnosis , Hepatitis, Autoimmune/drug therapy , Humans , Immunosuppressive Agents/therapeutic use , Liver Cirrhosis/drug therapy , Liver Cirrhosis/etiology , Male , Middle Aged , Outcome Assessment, Health Care , Prognosis , Survival Analysis
19.
Clin Liver Dis ; 9(2): 281-5, vii, 2005 May.
Article in English | MEDLINE | ID: mdl-15831273

ABSTRACT

Dysplastic nodules are the precursor lesions of hepatocellular carcinoma (HCC). Accurate diagnosis of dysplastic nodules and well-differentiated HCC is difficult with biopsy samples. Lesions often have regional variation of severity. Invasion of stroma, although a useful criterion of carcinoma, is seldom found on needle biopsies. Many criteria of neoplasia, such as widened plates and mitotic activity, are also found in reactive states. Thus, clinical history needs to be taken into consideration. No single criterion is sufficient for diagnosis of HCC. The best criteria for differentiation from dysplastic nodules on needle biopsies are (1) liver cell plates more than two cells in width or atypical plate structure, (2) high N/C ratio, and (3) nuclear atypia. The Laennec Classification of Hepatic Neoplasia may assist the standardization of these criteria.


Subject(s)
Biopsy, Needle/methods , Carcinoma, Hepatocellular/pathology , Liver Neoplasms/pathology , Lymph Nodes/pathology , Neoplasm Invasiveness/pathology , Carcinoma, Hepatocellular/diagnosis , Female , Humans , Liver Neoplasms/diagnosis , Male , Neoplasm Staging , Sensitivity and Specificity
20.
Am J Pathol ; 165(3): 889-99, 2004 Sep.
Article in English | MEDLINE | ID: mdl-15331413

ABSTRACT

In many different liver diseases, such as cirrhosis, degradation of the microcirculation, including obliteration of small portal or hepatic veins contributes to disease-associated portal hypertension. The present study demonstrates the importance of angiogenesis in the establishment of arteriovenous shunts and the accompanying changes to the venous bed. One aspect of angiogenesis involves the branching of new vessels from pre-existing ones, and the molecular mechanisms controlling it are complex and involve a coordinated effort between specific endothelial growth factors and their receptors, including the angiopoietins. We modulated the hepatic vasculature in mice by conditionally expressing angiopoietin-1 in hepatocytes. In mice exposed to angiopoietin-1 during development, arterial sprouting, enlarged arteries, marked loss of portal vein radicles, hepatic vein dilation, and suggestion of arteriovenous shunting were observed. Most importantly, these phenotypic changes were completely reversed within 14 days of turning off transgene expression. Expression of excess angiopoietin-1 beginning in adulthood did not fully recapitulate the phenotype, but did result in enlarged vessels. Our findings suggest that controlling excessive angiogenesis during liver disease may promote the restoration of the portal vein circuit and aid in the resolution of disease-associated portal hypertension.


Subject(s)
Angiopoietin-1/metabolism , Arteriovenous Fistula , Hepatic Artery/pathology , Hepatic Veins/pathology , Hypertension, Portal , Liver Circulation , Portal Vein/pathology , Angiopoietin-1/genetics , Animals , Arteriovenous Fistula/complications , Arteriovenous Fistula/pathology , Arteriovenous Fistula/prevention & control , Female , Hepatic Artery/metabolism , Hepatic Veins/metabolism , Hepatocytes/metabolism , Humans , Hypertension, Portal/etiology , Hypertension, Portal/prevention & control , Male , Mice , Mice, Transgenic , Microcirculation/pathology , Neovascularization, Pathologic , Phenotype , Portal Vein/metabolism , Transgenes/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...